Track the 科研製薬株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Market capitalisation: €148.1bn. The latest transaction was reported on 26 November 2024 (Holding update). Among the most active insiders: ―. Every trade is openly available.
Analysts rate 科研製薬株式会社 Hold (neutral), based on 4 analysts. Average price target: JP¥4,500.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Kaken Pharmaceutical Co., Ltd. 是一家日本公司,专注于药品的研究和开发。该公司在 XTKS 市场上市。